World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 6 October 2015
Main ID:  NCT02096250
Date of registration: 21/03/2014
Prospective Registration: Yes
Primary sponsor: Swiss Federal Institute of Technology
Public title: Iron Absorption in Haiti
Scientific title: Iron Absorption From Wheat Flour in Haiti
Date of first enrolment: June 2014
Target sample size: 44
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02096250
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science  
Phase:  N/A
Countries of recruitment
Haiti
Contacts
Name:     Isabelle Aeberli, PhD
Address: 
Telephone:
Email:
Affiliation:  ETH Zurich, Switzerland
Key inclusion & exclusion criteria

Mother-child pairs will be recruited!

Inclusion criteria for mothers :

- Women of reproductive age (18 to 45 years)

- Generally healthy

- Consenting to study participation

Exclusion criteria for mothers :

- Pregnancy or lactation

- Weight >65 kg

- Chronic illnesses which may influence iron absorption

- Severe anemia (Hb<10 g/dl)

Inclusion criteria for children:

- Age 4 years +/- 12 months

- Generally healthy

Exclusion criteria for children :

- Severe anemia (Hb<10 g/dl)

- Weight for height < -2 Z scores (wasting)

- Height of age < -2 Z score (stunting)

Furthermore, the following exclusion criteria apply to both mothers and children :

- Chronic illnesses or medication which may influence iron absorption (will be judged
by investigator)

- Consumption of vitamin or mineral supplement (unless they agree to discontinue using
them two weeks before beginning of the study until the las visit)

- Allergies or intolerances relevant to the test meal (gluten)

- Blood donation or major blood losses during the 2 months prior to the study

- Illness during the 4 weeks prior to the study (will be judged by investigator)



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Iron Deficiency
Intervention(s)
Other: NaFeEDTA + ferrous fumarate
Other: Ferrous fumarate
Other: NaFeEDTA
Primary Outcome(s)
Iron absorption [Time Frame: 14 days after test meal consumption]
Secondary Outcome(s)
Secondary ID(s)
EK 2013-N43
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
International Atomic Energy Agency
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history